EP Patent

EP0982300A2 — Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications

Assigned to Bioprojet SC · Expires 2000-03-01 · 26y expired

What this patent protects

Compounds of formula (A): <CHEM> wherein: W is a residue which imparts antagonistic and/or agonistic activity at histamine H3-receptors when attached to an imidazole ring in 4(5) position. R<1> and R<2> may be identical or different and represent each indepen…

USPTO Abstract

Compounds of formula (A): <CHEM> wherein: W is a residue which imparts antagonistic and/or agonistic activity at histamine H3-receptors when attached to an imidazole ring in 4(5) position. R<1> and R<2> may be identical or different and represent each independently a lower alkyl or cycloalkyl, or taken together with the nitrogen atom to which they are attached, a saturated nitrogen-containing ring (i) as defined, a non-aromatic unsaturated nitrogen-containing ring (ii) as defined, a morpholino group, or a N-substituted piperazino group as defined. Compounds (A) are useful for preparing medicaments acting as antagonists and/or agonists at the H3-receptors of histamine.

Drugs covered by this patent

Patent Metadata

Patent number
EP0982300A2
Jurisdiction
EP
Classification
Expires
2000-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Bioprojet SC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.